These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 32494680)

  • 1. Cellular backpacks for macrophage immunotherapy.
    Shields CW; Evans MA; Wang LL; Baugh N; Iyer S; Wu D; Zhao Z; Pusuluri A; Ukidve A; Pan DC; Mitragotri S
    Sci Adv; 2020 May; 6(18):eaaz6579. PubMed ID: 32494680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polyhydroxylated fullerenols regulate macrophage for cancer adoptive immunotherapy and greatly inhibit the tumor metastasis.
    Tang J; Chen Z; Sun B; Dong J; Liu J; Zhou H; Wang L; Bai R; Miao Q; Zhao Y; Chen C; Liu Y
    Nanomedicine; 2016 May; 12(4):945-954. PubMed ID: 26733256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineered CAR-Macrophages as Adoptive Immunotherapies for Solid Tumors.
    Sloas C; Gill S; Klichinsky M
    Front Immunol; 2021; 12():783305. PubMed ID: 34899748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ginseng-derived nanoparticles alter macrophage polarization to inhibit melanoma growth.
    Cao M; Yan H; Han X; Weng L; Wei Q; Sun X; Lu W; Wei Q; Ye J; Cai X; Hu C; Yin X; Cao P
    J Immunother Cancer; 2019 Nov; 7(1):326. PubMed ID: 31775862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dietary Protein Restriction Reprograms Tumor-Associated Macrophages and Enhances Immunotherapy.
    Orillion A; Damayanti NP; Shen L; Adelaiye-Ogala R; Affronti H; Elbanna M; Chintala S; Ciesielski M; Fontana L; Kao C; Elzey BD; Ratliff TL; Nelson DE; Smiraglia D; Abrams SI; Pili R
    Clin Cancer Res; 2018 Dec; 24(24):6383-6395. PubMed ID: 30190370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory effects of CuInS
    Yao CX; Lin TY; Su YL; Zou H; Yan ZY; Wu SM
    Enzyme Microb Technol; 2019 Aug; 127():50-57. PubMed ID: 31088616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid-based phagocytosis nanoenhancer for macrophage immunotherapy.
    Ramesh A; Kumar S; Nguyen A; Brouillard A; Kulkarni A
    Nanoscale; 2020 Jan; 12(3):1875-1885. PubMed ID: 31903467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanopatterned bulk metallic glass-based biomaterials modulate macrophage polarization.
    Shayan M; Padmanabhan J; Morris AH; Cheung B; Smith R; Schroers J; Kyriakides TR
    Acta Biomater; 2018 Jul; 75():427-438. PubMed ID: 29859902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetically engineered macrophages persist in solid tumors and locally deliver therapeutic proteins to activate immune responses.
    Brempelis KJ; Cowan CM; Kreuser SA; Labadie KP; Prieskorn BM; Lieberman NAP; Ene CI; Moyes KW; Chinn H; DeGolier KR; Matsumoto LR; Daniel SK; Yokoyama JK; Davis AD; Hoglund VJ; Smythe KS; Balcaitis SD; Jensen MC; Ellenbogen RG; Campbell JS; Pierce RH; Holland EC; Pillarisetty VG; Crane CA
    J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33115946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophage-Mediated Tumor Cell Phagocytosis: Opportunity for Nanomedicine Intervention.
    Zhou X; Liu X; Huang L
    Adv Funct Mater; 2021 Jan; 31(5):. PubMed ID: 33692665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of tumor-associated macrophages by the vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid induces an effective CD8+ T-cell-mediated antitumor immune response in murine models of lung cancer and mesothelioma.
    Jassar AS; Suzuki E; Kapoor V; Sun J; Silverberg MB; Cheung L; Burdick MD; Strieter RM; Ching LM; Kaiser LR; Albelda SM
    Cancer Res; 2005 Dec; 65(24):11752-61. PubMed ID: 16357188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrophage activation by a substituted pyrimido[5,4-b]indole increases anti-cancer activity.
    Hardie J; Mas-Rosario JA; Ha S; Rizzo EM; Farkas ME
    Pharmacol Res; 2019 Oct; 148():104452. PubMed ID: 31518642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical debulking promotes recruitment of macrophages and triggers glioblastoma phagocytosis in combination with CD47 blocking immunotherapy.
    Zhu H; Leiss L; Yang N; Rygh CB; Mitra SS; Cheshier SH; Weissman IL; Huang B; Miletic H; Bjerkvig R; Enger PØ; Li X; Wang J
    Oncotarget; 2017 Feb; 8(7):12145-12157. PubMed ID: 28076333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adoptive immunotherapy of solid tumors with activated macrophages: experimental and clinical results.
    Bartholeyns J; Lopez M; Andreesen R
    Anticancer Res; 1991; 11(3):1201-4. PubMed ID: 1888150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies for enhancing adoptive T-cell immunotherapy against solid tumors using engineered cytokine signaling and other modalities.
    Shum T; Kruse RL; Rooney CM
    Expert Opin Biol Ther; 2018 Jun; 18(6):653-664. PubMed ID: 29727246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunopotentiating effect of proton pump inhibitor pantoprazole in a lymphoma-bearing murine host: Implication in antitumor activation of tumor-associated macrophages.
    Vishvakarma NK; Singh SM
    Immunol Lett; 2010 Nov; 134(1):83-92. PubMed ID: 20837061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimizing NK Cell-Based Immunotherapy in Myeloid Leukemia: Abrogating an Immunosuppressive Microenvironment.
    Kaweme NM; Zhou F
    Front Immunol; 2021; 12():683381. PubMed ID: 34220833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Signaling pathways for tumor necrosis factor-alpha and interleukin-6 expression in human macrophages exposed to titanium-alloy particulate debris in vitro.
    Nakashima Y; Sun DH; Trindade MC; Maloney WJ; Goodman SB; Schurman DJ; Smith RL
    J Bone Joint Surg Am; 1999 May; 81(5):603-15. PubMed ID: 10360689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor activation of peritoneal macrophages by thymosin alpha-1.
    Shrivastava P; Singh SM; Singh N
    Cancer Invest; 2005; 23(4):316-22. PubMed ID: 16100944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophage-biomimetic porous Se@SiO
    Ding C; Yang C; Cheng T; Wang X; Wang Q; He R; Sang S; Zhu K; Xu D; Wang J; Liu X; Zhang X
    J Nanobiotechnology; 2021 Nov; 19(1):382. PubMed ID: 34809618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.